Eric J. Aulicino is Chief Executive Officer of LifeAire Systems, where he leads the company’s global commercial strategy, operational scaling, and market expansion across IVF, healthcare, life sciences, cell and gene therapy, and critical infrastructure applications.

Eric brings more than three decades of global executive leadership to the role. Prior to his appointment as CEO, he served as a strategic advisor to LifeAire’s commercial team and Board of Directors, providing direction on commercialization, growth planning, and market development. His transition from advisor to CEO reflects both his deep familiarity with the company and his commitment to the mission of advancing medical grade air purification as a standard of care across the environments LifeAire serves.

His career spans 25 years of international executive experience across Europe, China, and India, leading complex business transformations, cross-border integrations, and market entry strategies for companies operating in highly regulated and technically demanding industries. This global perspective informs his approach to building LifeAire’s international presence and distributor network, and to positioning the company’s peer-reviewed, patented technology for adoption by leading healthcare institutions and life sciences organizations worldwide.

Eric also leads EBITDA Intl. Consulting, through which he advises companies on M&A strategy, operational efficiency, and global market entry. This parallel advisory practice reflects a career built on translating scientific and technical innovation into sustainable commercial outcomes — a capability that directly supports LifeAire’s growth trajectory as it scales from a recognized leader in IVF air purification to a global platform serving the full continuum of clinical care.